Symbol:
Phldb2
Name:
pleckstrin homology-like domain, family B, member 2
RGD ID:
1591402
Description:
Predicted to be involved in several processes, including negative regulation of focal adhesion assembly; regulation of cytoskeleton organization; and regulation of embryonic development. Predicted to be located in several cellular components, including cell leading edge; cytoskeleton; and focal adhesion. Predicted to be active in basal cortex. Orthologous to human PHLDB2 (pleckstrin homology like domain family B member 2); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC685611; NEWGENE_1591402; pleckstrin homology like domain family B member 2; pleckstrin homology-like domain family B member 2; similar to pleckstrin homology-like domain, family B, member 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PHLDB2 (pleckstrin homology like domain family B member 2) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Phldb2 (pleckstrin homology like domain, family B, member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Phldb2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PHLDB2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PHLDB2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Phldb2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PHLDB2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
PHLDB2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Phldb2 (pleckstrin homology like domain family B member 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
CCDC92 (coiled-coil domain containing 92) HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
PHLDB2 (pleckstrin homology like domain family B member 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Phldb2 (pleckstrin homology like domain, family B, member 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
phldb2b (pleckstrin homology-like domain, family B, member 2b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG5004
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 11 68,321,738 - 68,540,724 (+) NCBI GRCr8 mRatBN7.2 11 54,859,173 - 55,078,212 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 11 54,859,135 - 55,078,467 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 11 60,042,879 - 60,051,229 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 11 57,265,732 - 57,481,589 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 11 60,429,481 - 60,646,262 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 11 56,484,223 - 56,564,459 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 11 54,388,307 - 54,601,451 (+) NCBI Celera Cytogenetic Map 11 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Phldb2 Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1558249 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PHLDB2 mRNA CTD PMID:22206623 Phldb2 Rat 1,2-dimethylhydrazine increases expression ISO RGD:1558249 6480464 1,2-Dimethylhydrazine results in increased expression of PHLDB2 mRNA CTD PMID:22206623 Phldb2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PHLDB2 mRNA CTD PMID:32145629 Phldb2 Rat 17beta-estradiol affects expression ISO RGD:1558249 6480464 Estradiol affects the expression of PHLDB2 mRNA CTD PMID:39298647 Phldb2 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1350676 6480464 Dihydrotestosterone results in increased expression of PHLDB2 mRNA CTD PMID:29581250 Phldb2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558249 6480464 Tetrachlorodibenzodioxin results in decreased expression of PHLDB2 mRNA CTD PMID:19770486|PMID:33956508 Phldb2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PHLDB2 mRNA CTD PMID:32109520|PMID:33387578 Phldb2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558249 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression more ... CTD PMID:25975270 Phldb2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1350676 6480464 Tetrachlorodibenzodioxin results in increased expression of PHLDB2 mRNA CTD PMID:20106945|PMID:21632981 Phldb2 Rat 2,6-dimethoxyphenol multiple interactions ISO RGD:1350676 6480464 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the more ... CTD PMID:38598786 Phldb2 Rat 2-hydroxypropanoic acid increases expression ISO RGD:1350676 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 Phldb2 Rat 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1558249 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PHLDB2 mRNA CTD PMID:26251327 Phldb2 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1558249 6480464 bisphenol S results in increased expression of PHLDB2 mRNA CTD PMID:30951980 Phldb2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1350676 6480464 bisphenol S results in decreased methylation of PHLDB2 gene CTD PMID:31601247 Phldb2 Rat 4,4'-sulfonyldiphenol affects expression ISO RGD:1558249 6480464 bisphenol S affects the expression of PHLDB2 mRNA CTD PMID:39298647 Phldb2 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:1558249 6480464 Fenretinide results in increased expression of PHLDB2 mRNA CTD PMID:28973697 Phldb2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PHLDB2 mRNA CTD PMID:24780913|PMID:25825206 Phldb2 Rat aflatoxin B1 increases expression ISO RGD:1558249 6480464 Aflatoxin B1 results in increased expression of PHLDB2 mRNA CTD PMID:19770486 Phldb2 Rat aflatoxin B1 decreases methylation ISO RGD:1350676 6480464 Aflatoxin B1 results in decreased methylation of PHLDB2 gene CTD PMID:27153756 Phldb2 Rat antirheumatic drug increases expression ISO RGD:1350676 6480464 Antirheumatic Agents results in increased expression of PHLDB2 mRNA CTD PMID:24449571 Phldb2 Rat aristolochic acid A decreases expression ISO RGD:1350676 6480464 aristolochic acid I results in decreased expression of PHLDB2 mRNA CTD PMID:33212167 Phldb2 Rat arsenous acid increases expression ISO RGD:1350676 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 Phldb2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PHLDB2 gene CTD PMID:35440735 Phldb2 Rat benzo[a]pyrene decreases expression ISO RGD:1558249 6480464 Benzo(a)pyrene results in decreased expression of PHLDB2 mRNA CTD PMID:19770486 Phldb2 Rat benzo[a]pyrene affects methylation ISO RGD:1350676 6480464 Benzo(a)pyrene affects the methylation of PHLDB2 exon; Benzo(a)pyrene affects the methylation of PHLDB2 promoter CTD PMID:27901495|PMID:30157460 Phldb2 Rat benzo[a]pyrene decreases methylation ISO RGD:1350676 6480464 Benzo(a)pyrene results in decreased methylation of PHLDB2 5' UTR CTD PMID:27901495 Phldb2 Rat benzo[a]pyrene decreases expression ISO RGD:1350676 6480464 Benzo(a)pyrene results in decreased expression of PHLDB2 protein CTD PMID:32717239 Phldb2 Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350676 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHLDB2 mRNA CTD PMID:19150397|PMID:20382639 Phldb2 Rat bisphenol A increases expression ISO RGD:1558249 6480464 bisphenol A results in increased expression of PHLDB2 mRNA CTD PMID:26063408|PMID:30951980|PMID:33221593|PMID:34585602 Phldb2 Rat bisphenol A affects methylation ISO RGD:1350676 6480464 bisphenol A affects the methylation of PHLDB2 gene CTD PMID:31601247 Phldb2 Rat bisphenol A multiple interactions ISO RGD:1350676 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PHLDB2 gene CTD PMID:31601247 Phldb2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PHLDB2 mRNA CTD PMID:25181051|PMID:32145629|PMID:34947998|PMID:35192832|PMID:38750585 Phldb2 Rat bisphenol F increases expression ISO RGD:1558249 6480464 bisphenol F results in increased expression of PHLDB2 mRNA CTD PMID:30951980 Phldb2 Rat butanal decreases expression ISO RGD:1350676 6480464 butyraldehyde results in decreased expression of PHLDB2 mRNA CTD PMID:26079696 Phldb2 Rat cadmium dichloride increases expression ISO RGD:1350676 6480464 Cadmium Chloride results in increased expression of PHLDB2 mRNA CTD PMID:26472689 Phldb2 Rat caffeine affects phosphorylation ISO RGD:1350676 6480464 Caffeine affects the phosphorylation of PHLDB2 protein CTD PMID:35688186 Phldb2 Rat calcitriol increases expression ISO RGD:1350676 6480464 Calcitriol results in increased expression of PHLDB2 mRNA CTD PMID:16002434 Phldb2 Rat cannabidiol increases expression ISO RGD:1350676 6480464 Cannabidiol results in increased expression of PHLDB2 mRNA CTD PMID:33244087 Phldb2 Rat carbamazepine affects expression ISO RGD:1350676 6480464 Carbamazepine affects the expression of PHLDB2 mRNA CTD PMID:25979313 Phldb2 Rat CGP 52608 multiple interactions ISO RGD:1350676 6480464 CGP 52608 promotes the reaction [RORA protein binds to PHLDB2 gene] CTD PMID:28238834 Phldb2 Rat chlorpyrifos decreases expression ISO RGD:1558249 6480464 Chlorpyrifos results in decreased expression of PHLDB2 mRNA CTD PMID:37019170 Phldb2 Rat choline multiple interactions ISO RGD:1558249 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Phldb2 Rat cisplatin multiple interactions ISO RGD:1350676 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 Phldb2 Rat cisplatin decreases expression ISO RGD:1350676 6480464 Cisplatin results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 Phldb2 Rat cobalt dichloride decreases expression ISO RGD:1350676 6480464 cobaltous chloride results in decreased expression of PHLDB2 mRNA CTD PMID:19320972 Phldb2 Rat copper atom multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 Phldb2 Rat copper(0) multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 Phldb2 Rat copper(II) sulfate decreases expression ISO RGD:1350676 6480464 Copper Sulfate results in decreased expression of PHLDB2 mRNA CTD PMID:19549813 Phldb2 Rat coumarin decreases phosphorylation ISO RGD:1350676 6480464 coumarin results in decreased phosphorylation of PHLDB2 protein CTD PMID:35688186 Phldb2 Rat coumestrol multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Phldb2 Rat crocidolite asbestos decreases expression ISO RGD:1558249 6480464 Asbestos, Crocidolite results in decreased expression of PHLDB2 mRNA CTD PMID:29279043 Phldb2 Rat crocidolite asbestos decreases expression ISO RGD:1350676 6480464 Asbestos, Crocidolite results in decreased expression of PHLDB2 mRNA CTD PMID:29523930 Phldb2 Rat cyclosporin A decreases expression ISO RGD:1350676 6480464 Cyclosporine results in decreased expression of PHLDB2 mRNA CTD PMID:20106945 Phldb2 Rat cyclosporin A affects expression ISO RGD:1350676 6480464 Cyclosporine affects the expression of PHLDB2 mRNA CTD PMID:25562108 Phldb2 Rat dexamethasone decreases expression ISO RGD:1558249 6480464 Dexamethasone results in decreased expression of PHLDB2 mRNA CTD PMID:22733784 Phldb2 Rat diarsenic trioxide increases expression ISO RGD:1350676 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 Phldb2 Rat dibutyl phthalate increases expression ISO RGD:1558249 6480464 Dibutyl Phthalate results in increased expression of PHLDB2 mRNA CTD PMID:17361019|PMID:21266533 Phldb2 Rat disulfiram multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 Phldb2 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of PHLDB2 mRNA CTD PMID:25152437 Phldb2 Rat dorsomorphin multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Phldb2 Rat Enterolactone multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 Phldb2 Rat ethyl methanesulfonate decreases expression ISO RGD:1350676 6480464 Ethyl Methanesulfonate results in decreased expression of PHLDB2 mRNA CTD PMID:23649840 Phldb2 Rat fenamidone increases expression ISO RGD:1558249 6480464 fenamidone results in increased expression of PHLDB2 mRNA CTD PMID:27029645 Phldb2 Rat folic acid multiple interactions ISO RGD:1558249 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PHLDB2 mRNA; [Methionine deficiency co-treated more ... CTD PMID:20938992|PMID:22206623 Phldb2 Rat FR900359 affects phosphorylation ISO RGD:1350676 6480464 FR900359 affects the phosphorylation of PHLDB2 protein CTD PMID:37730182 Phldb2 Rat fulvestrant multiple interactions ISO RGD:1350676 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PHLDB2 gene CTD PMID:31601247 Phldb2 Rat fulvestrant increases methylation ISO RGD:1350676 6480464 Fulvestrant results in increased methylation of PHLDB2 gene CTD PMID:31601247 Phldb2 Rat furfural multiple interactions ISO RGD:1350676 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 Phldb2 Rat geldanamycin increases expression ISO RGD:1350676 6480464 geldanamycin results in increased expression of PHLDB2 mRNA CTD PMID:26705709 Phldb2 Rat glyphosate decreases methylation EXP 6480464 Glyphosate results in decreased methylation of PHLDB2 gene CTD PMID:31011160 Phldb2 Rat hexadecanoic acid decreases phosphorylation ISO RGD:1350676 6480464 Palmitic Acid results in decreased phosphorylation of PHLDB2 protein CTD PMID:28073184 Phldb2 Rat isobutanol multiple interactions ISO RGD:1350676 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic more ... CTD PMID:29432896 Phldb2 Rat ivermectin decreases expression ISO RGD:1350676 6480464 Ivermectin results in decreased expression of PHLDB2 protein CTD PMID:32959892 Phldb2 Rat L-methionine multiple interactions ISO RGD:1558249 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Phldb2 Rat Licochalcone B decreases expression ISO RGD:1350676 6480464 licochalcone B results in decreased expression of PHLDB2 mRNA CTD PMID:33647349 Phldb2 Rat lipopolysaccharide multiple interactions ISO RGD:1350676 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHLDB2 mRNA CTD PMID:35811015 Phldb2 Rat melphalan decreases expression ISO RGD:1350676 6480464 Melphalan results in decreased expression of PHLDB2 mRNA CTD PMID:22363485 Phldb2 Rat nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 Phldb2 Rat nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 Phldb2 Rat ochratoxin A decreases expression ISO RGD:1350676 6480464 ochratoxin A results in decreased expression of PHLDB2 mRNA CTD PMID:30559759 Phldb2 Rat okadaic acid affects expression ISO RGD:1350676 6480464 Okadaic Acid affects the expression of PHLDB2 protein CTD PMID:38832940 Phldb2 Rat paracetamol affects expression ISO RGD:1558249 6480464 Acetaminophen affects the expression of PHLDB2 mRNA CTD PMID:17562736 Phldb2 Rat paracetamol decreases expression ISO RGD:1350676 6480464 Acetaminophen results in decreased expression of PHLDB2 mRNA CTD PMID:21420995 Phldb2 Rat phenobarbital affects expression ISO RGD:1558249 6480464 Phenobarbital affects the expression of PHLDB2 mRNA CTD PMID:23091169 Phldb2 Rat pirinixic acid decreases expression ISO RGD:1558249 6480464 pirinixic acid results in decreased expression of PHLDB2 mRNA CTD PMID:18445702 Phldb2 Rat quercetin decreases expression ISO RGD:1350676 6480464 Quercetin results in decreased expression of PHLDB2 mRNA CTD PMID:21632981 Phldb2 Rat rac-lactic acid increases expression ISO RGD:1350676 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 Phldb2 Rat resveratrol multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 Phldb2 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of PHLDB2 mRNA CTD PMID:28374803 Phldb2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1350676 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHLDB2 mRNA CTD PMID:35811015 Phldb2 Rat SB 431542 multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Phldb2 Rat silicon dioxide increases expression ISO RGD:1350676 6480464 Silicon Dioxide analog results in increased expression of PHLDB2 mRNA CTD PMID:25895662 Phldb2 Rat silver atom increases expression ISO RGD:1350676 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 Phldb2 Rat silver atom decreases expression ISO RGD:1350676 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 Phldb2 Rat silver(0) increases expression ISO RGD:1350676 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 Phldb2 Rat silver(0) decreases expression ISO RGD:1350676 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 Phldb2 Rat sodium arsenite decreases expression ISO RGD:1350676 6480464 sodium arsenite results in decreased expression of PHLDB2 mRNA CTD PMID:12679051|PMID:34032870|PMID:38568856 Phldb2 Rat sodium chloride multiple interactions ISO RGD:1350676 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 Phldb2 Rat sunitinib decreases expression ISO RGD:1350676 6480464 Sunitinib results in decreased expression of PHLDB2 mRNA CTD PMID:31533062 Phldb2 Rat tetrachloromethane affects expression ISO RGD:1558249 6480464 Carbon Tetrachloride affects the expression of PHLDB2 mRNA CTD PMID:17484886|PMID:31919559 Phldb2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PHLDB2 mRNA CTD PMID:31150632 Phldb2 Rat tetrachloromethane increases expression ISO RGD:1558249 6480464 Carbon Tetrachloride results in increased expression of PHLDB2 mRNA CTD PMID:27339419 Phldb2 Rat thimerosal decreases expression ISO RGD:1350676 6480464 Thimerosal results in decreased expression of PHLDB2 mRNA CTD PMID:27188386 Phldb2 Rat thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of PHLDB2 mRNA CTD PMID:34492290 Phldb2 Rat thiram decreases expression ISO RGD:1350676 6480464 Thiram results in decreased expression of PHLDB2 mRNA CTD PMID:38568856 Phldb2 Rat titanium dioxide affects expression ISO RGD:1558249 6480464 titanium dioxide affects the expression of PHLDB2 mRNA CTD PMID:23557971 Phldb2 Rat titanium dioxide decreases methylation ISO RGD:1558249 6480464 titanium dioxide results in decreased methylation of PHLDB2 gene CTD PMID:35295148 Phldb2 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PHLDB2 mRNA CTD PMID:33387578 Phldb2 Rat trichostatin A increases expression ISO RGD:1350676 6480464 trichostatin A results in increased expression of PHLDB2 mRNA CTD PMID:24935251 Phldb2 Rat triclosan increases expression ISO RGD:1350676 6480464 Triclosan results in increased expression of PHLDB2 mRNA CTD PMID:30510588 Phldb2 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PHLDB2 mRNA CTD PMID:30589522 Phldb2 Rat triphenyl phosphate affects expression ISO RGD:1350676 6480464 triphenyl phosphate affects the expression of PHLDB2 mRNA CTD PMID:37042841 Phldb2 Rat triptonide increases expression ISO RGD:1558249 6480464 triptonide results in increased expression of PHLDB2 mRNA CTD PMID:33045310 Phldb2 Rat troglitazone decreases expression ISO RGD:1350676 6480464 troglitazone results in decreased expression of PHLDB2 mRNA CTD PMID:25572481 Phldb2 Rat urethane decreases expression ISO RGD:1350676 6480464 Urethane results in decreased expression of PHLDB2 mRNA CTD PMID:28818685 Phldb2 Rat valproic acid decreases methylation ISO RGD:1350676 6480464 Valproic Acid results in decreased methylation of PHLDB2 gene CTD PMID:29154799 Phldb2 Rat valproic acid affects expression ISO RGD:1350676 6480464 Valproic Acid affects the expression of PHLDB2 mRNA CTD PMID:25979313 Phldb2 Rat valproic acid increases expression ISO RGD:1350676 6480464 Valproic Acid results in increased expression of PHLDB2 mRNA CTD PMID:23179753|PMID:24935251|PMID:26272509 Phldb2 Rat valproic acid multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Phldb2 Rat vorinostat affects expression ISO RGD:1350676 6480464 vorinostat affects the expression of PHLDB2 mRNA CTD PMID:27188386
1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,6-dimethoxyphenol (ISO) 2-hydroxypropanoic acid (ISO) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) antirheumatic drug (ISO) aristolochic acid A (ISO) arsenous acid (ISO) atrazine (EXP) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) butanal (ISO) cadmium dichloride (ISO) caffeine (ISO) calcitriol (ISO) cannabidiol (ISO) carbamazepine (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) choline (ISO) cisplatin (ISO) cobalt dichloride (ISO) copper atom (ISO) copper(0) (ISO) copper(II) sulfate (ISO) coumarin (ISO) coumestrol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dexamethasone (ISO) diarsenic trioxide (ISO) dibutyl phthalate (ISO) disulfiram (ISO) diuron (EXP) dorsomorphin (ISO) Enterolactone (ISO) ethyl methanesulfonate (ISO) fenamidone (ISO) folic acid (ISO) FR900359 (ISO) fulvestrant (ISO) furfural (ISO) geldanamycin (ISO) glyphosate (EXP) hexadecanoic acid (ISO) isobutanol (ISO) ivermectin (ISO) L-methionine (ISO) Licochalcone B (ISO) lipopolysaccharide (ISO) melphalan (ISO) nefazodone (EXP) nimesulide (EXP) ochratoxin A (ISO) okadaic acid (ISO) paracetamol (ISO) phenobarbital (ISO) pirinixic acid (ISO) quercetin (ISO) rac-lactic acid (ISO) resveratrol (ISO) rotenone (EXP) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium chloride (ISO) sunitinib (ISO) tetrachloromethane (EXP,ISO) thimerosal (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (EXP,ISO) triptonide (ISO) troglitazone (ISO) urethane (ISO) valproic acid (ISO) vorinostat (ISO)
Phldb2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 11 68,321,738 - 68,540,724 (+) NCBI GRCr8 mRatBN7.2 11 54,859,173 - 55,078,212 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 11 54,859,135 - 55,078,467 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 11 60,042,879 - 60,051,229 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 11 57,265,732 - 57,481,589 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 11 60,429,481 - 60,646,262 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 11 56,484,223 - 56,564,459 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 11 54,388,307 - 54,601,451 (+) NCBI Celera Cytogenetic Map 11 q21 NCBI
PHLDB2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 111,732,496 - 111,976,517 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 111,732,497 - 111,976,517 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 111,451,343 - 111,695,364 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 113,085,500 - 113,177,826 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 113,085,499 - 113,177,809 NCBI Celera 3 109,851,286 - 110,094,444 (+) NCBI Celera Cytogenetic Map 3 q13.2 NCBI HuRef 3 108,826,722 - 109,070,708 (+) NCBI HuRef CHM1_1 3 111,415,675 - 111,659,409 (+) NCBI CHM1_1 T2T-CHM13v2.0 3 114,453,343 - 114,697,610 (+) NCBI T2T-CHM13v2.0
Phldb2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 16 45,566,593 - 45,773,961 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 16 45,566,606 - 45,773,961 (-) Ensembl GRCm39 Ensembl GRCm38 16 45,746,230 - 45,953,598 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 16 45,746,243 - 45,953,598 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 16 45,746,346 - 45,844,491 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 16 45,665,575 - 45,763,715 (-) NCBI MGSCv36 mm8 Celera 16 46,122,635 - 46,220,830 (-) NCBI Celera Cytogenetic Map 16 B5 NCBI cM Map 16 30.08 NCBI
Phldb2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955427 12,273,062 - 12,388,217 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955427 12,284,100 - 12,385,755 (+) NCBI ChiLan1.0 ChiLan1.0
PHLDB2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 109,844,347 - 109,975,856 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 109,849,118 - 109,980,637 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 108,878,798 - 109,120,501 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 115,803,869 - 116,044,586 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 115,745,634 - 116,044,586 (+) Ensembl panpan1.1 panPan2
PHLDB2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 33 16,521,087 - 16,615,774 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 33 16,497,202 - 16,614,132 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 33 16,500,237 - 16,717,632 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 33 16,635,502 - 16,853,682 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 33 16,737,741 - 16,853,566 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 33 16,446,434 - 16,663,884 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 33 16,492,184 - 16,707,808 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 33 17,037,057 - 17,254,141 (+) NCBI UU_Cfam_GSD_1.0
Phldb2
PHLDB2
PHLDB2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 22 68,821,958 - 69,059,087 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 22 68,821,742 - 69,059,087 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 97,417,840 - 97,653,649 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Phldb2
.
Predicted Target Of
Count of predictions: 110 Count of miRNA genes: 80 Interacting mature miRNAs: 86 Transcripts: ENSRNOT00000034097, ENSRNOT00000042754 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
1300147 Bp187 Blood pressure QTL 187 3.67 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 11 1 69446234 Rat 724554 Iddm17 Insulin dependent diabetes mellitus QTL 17 0.001 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 11 18976208 86241447 Rat 70180 BpQTLcluster10 Blood pressure QTL cluster 10 3.19 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 11 34918041 79918041 Rat 1581565 Pur10 Proteinuria QTL 10 0.0001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 11 44803318 82846466 Rat 4889859 Pur28 Proteinuria QTL 28 19.5 0.001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 11 45459323 75190161 Rat 8694376 Bw156 Body weight QTL 156 2.25 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 11 23280456 68280456 Rat 10755497 Bp388 Blood pressure QTL 388 2.76 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 11 19456205 76331918 Rat 10058952 Gmadr6 Adrenal mass QTL 6 2.29 0.0072 adrenal gland mass (VT:0010420) both adrenal glands wet weight to body weight ratio (CMO:0002411) 11 22959403 67959403 Rat 1300130 Rf20 Renal function QTL 20 4.44 kidney glomerulus integrity trait (VT:0010546) kidney glomerulus diameter (CMO:0001166) 11 29528418 60324829 Rat 1558659 Tescar1 Testicular tumor resistance QTL 1 3.9 testis integrity trait (VT:0010572) percentage of study population developing testis tumors during a period of time (CMO:0001261) 11 1041931 66113562 Rat 2298551 Neuinf10 Neuroinflammation QTL 10 3.7 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 11 31239134 78851519 Rat 1300135 Rf19 Renal function QTL 19 3.38 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 11 40946188 82566702 Rat 2312566 Glom20 Glomerulus QTL 20 3.6 0.001 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 11 44285759 82566702 Rat 724563 Uae10 Urinary albumin excretion QTL 10 6 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 11 27672410 82846715 Rat 9589032 Epfw10 Epididymal fat weight QTL 10 9.29 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 11 23280456 68280456 Rat 724561 Plsm4 Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 0.0003 forelimb integrity trait (VT:0010562) front foot phalanges count (CMO:0001947) 11 54457534 86241447 Rat 9590313 Scort20 Serum corticosterone level QTL 20 6.51 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 11 23280456 68280456 Rat 8694424 Bw162 Body weight QTL 162 3.8 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 11 23280456 68280456 Rat 1581572 Uae35 Urinary albumin excretion QTL 35 0.0001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 11 44803318 82846466 Rat 1300110 Stl7 Serum triglyceride level QTL 7 4.64 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 11 29528418 82566702 Rat
RH143382
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 11 55,033,616 - 55,033,794 (+) MAPPER mRatBN7.2 Rnor_6.0 11 57,438,982 - 57,439,159 NCBI Rnor6.0 Rnor_5.0 11 60,601,717 - 60,601,894 UniSTS Rnor5.0 RGSC_v3.4 11 56,521,549 - 56,521,726 UniSTS RGSC3.4 Celera 11 54,559,131 - 54,559,308 UniSTS RH 3.4 Map 1 1714.0 UniSTS Cytogenetic Map 11 q21 UniSTS
RH141831
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 11 55,076,683 - 55,076,888 (+) MAPPER mRatBN7.2 Rnor_6.0 11 57,481,709 - 57,481,913 NCBI Rnor6.0 Rnor_6.0 11 60,049,780 - 60,049,984 NCBI Rnor6.0 Rnor_5.0 11 60,644,477 - 60,644,681 UniSTS Rnor5.0 RGSC_v3.4 11 56,564,101 - 56,564,305 UniSTS RGSC3.4 RH 3.4 Map 4 622.53 UniSTS Cytogenetic Map 11 q21 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000034097 ⟹ ENSRNOP00000038800
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,998,343 - 55,077,164 (+) Ensembl Rnor_6.0 Ensembl 11 57,404,196 - 57,481,567 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000042754 ⟹ ENSRNOP00000049406
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,981,191 - 55,077,164 (+) Ensembl Rnor_6.0 Ensembl 11 57,404,196 - 57,481,567 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000086178 ⟹ ENSRNOP00000077973
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,981,197 - 55,078,467 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093174 ⟹ ENSRNOP00000076223
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,859,135 - 55,078,464 (+) Ensembl Rnor_6.0 Ensembl 11 57,265,732 - 57,405,518 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093201 ⟹ ENSRNOP00000076159
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,981,197 - 55,078,467 (+) Ensembl Rnor_6.0 Ensembl 11 57,430,166 - 57,481,589 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000114570 ⟹ ENSRNOP00000097614
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 11 54,981,191 - 55,078,126 (+) Ensembl
RefSeq Acc Id:
XM_039088877 ⟹ XP_038944805
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,173 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088878 ⟹ XP_038944806
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,443,775 - 68,540,724 (+) NCBI mRatBN7.2 11 54,981,160 - 55,078,191 (+) NCBI
RefSeq Acc Id:
XM_039088879 ⟹ XP_038944807
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088880 ⟹ XP_038944808
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088882 ⟹ XP_038944810
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088883 ⟹ XP_038944811
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088884 ⟹ XP_038944812
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088885 ⟹ XP_038944813
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088888 ⟹ XP_038944816
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,174 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_039088889 ⟹ XP_038944817
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI mRatBN7.2 11 54,859,175 - 55,078,212 (+) NCBI
RefSeq Acc Id:
XM_063270856 ⟹ XP_063126926
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI
RefSeq Acc Id:
XM_063270857 ⟹ XP_063126927
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI
RefSeq Acc Id:
XM_063270858 ⟹ XP_063126928
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,443,466 - 68,540,724 (+) NCBI
RefSeq Acc Id:
XM_063270859 ⟹ XP_063126929
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI
RefSeq Acc Id:
XM_063270860 ⟹ XP_063126930
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI
RefSeq Acc Id:
XM_063270861 ⟹ XP_063126931
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 11 68,321,738 - 68,540,724 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000038800 ⟸ ENSRNOT00000034097
Ensembl Acc Id:
ENSRNOP00000076223 ⟸ ENSRNOT00000093174
Ensembl Acc Id:
ENSRNOP00000076159 ⟸ ENSRNOT00000093201
Ensembl Acc Id:
ENSRNOP00000049406 ⟸ ENSRNOT00000042754
RefSeq Acc Id:
XP_038944805 ⟸ XM_039088877
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I5Y6J7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944807 ⟸ XM_039088879
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944808 ⟸ XM_039088880
- Peptide Label:
isoform X4
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944810 ⟸ XM_039088882
- Peptide Label:
isoform X5
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944811 ⟸ XM_039088883
- Peptide Label:
isoform X6
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944812 ⟸ XM_039088884
- Peptide Label:
isoform X8
- UniProtKB:
D3ZTL3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944816 ⟸ XM_039088888
- Peptide Label:
isoform X13
- UniProtKB:
D3ZTL3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944813 ⟸ XM_039088885
- Peptide Label:
isoform X9
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944817 ⟸ XM_039088889
- Peptide Label:
isoform X15
- UniProtKB:
D3ZTL3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038944806 ⟸ XM_039088878
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I5Y6J7 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000097614 ⟸ ENSRNOT00000114570
Ensembl Acc Id:
ENSRNOP00000077973 ⟸ ENSRNOT00000086178
RefSeq Acc Id:
XP_063126927 ⟸ XM_063270857
- Peptide Label:
isoform X10
RefSeq Acc Id:
XP_063126926 ⟸ XM_063270856
- Peptide Label:
isoform X7
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063126929 ⟸ XM_063270859
- Peptide Label:
isoform X12
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063126930 ⟸ XM_063270860
- Peptide Label:
isoform X14
- UniProtKB:
A0A8I6GM52 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063126931 ⟸ XM_063270861
- Peptide Label:
isoform X16
- UniProtKB:
D3ZTL3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063126928 ⟸ XM_063270858
- Peptide Label:
isoform X11
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Phldb2
pleckstrin homology-like domain, family B, member 2
NEWGENE_1591402
pleckstrin homology like domain family B member 2
Data merged from RGD:11480351
737654 PROVISIONAL
2016-08-02
NEWGENE_1591402
pleckstrin homology like domain family B member 2
Symbol and Name status set to provisional
70820 PROVISIONAL
2013-05-24
Phldb2
pleckstrin homology-like domain, family B, member 2
LOC360713
similar to pleckstrin homology-like domain, family B, member 2
Data merged from RGD:1590884
1643240 APPROVED
2008-03-05
Phldb2
pleckstrin homology-like domain, family B, member 2
LOC685611
similar to pleckstrin homology-like domain, family B, member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-11-20
LOC685611
similar to pleckstrin homology-like domain, family B, member 2
Symbol and Name status set to provisional
70820 PROVISIONAL
2006-11-20
LOC360713
similar to pleckstrin homology-like domain, family B, member 2
Symbol and Name status set to provisional
70820 PROVISIONAL
